课题基金 / 基金详情

MONONUCLEAR PHAGOCYTE-DERIVED GROWTH FACTOR

MONONUCLEAR PHAGOCYTE-DERIVED GROWTH FACTOR
单核吞噬细胞衍生的生长因子
批准号:
3169263
负责人:
G. YANCEY GILLESPIE
金额:
$12.31万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-06-01 至 1988-05-30

项目摘要

项目成果

G. YANCEY GILLESPIE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of this research is to develop our fundamental knowledge of the basic mechanism(s) by which mononuclear phagocytes regulate proliferation of various normal cell types. Our findings to date suggest that macrophages and macrophage-like cell lines elaborate specific soluble factor(s) that can cause quiescent fibroblasts to initiate traverse of the cell cycle. Operationally, this monokine(s) is a "competence" factor, similar in its action to other known competence factors (platelet-derived growth factor and fibroblast growth factor) but biochemically distinct from both. We have concentrated our efforts on purification of the macrophage-derived competence factor (MDCF) from spent supernates of cultured P388D1, a mouse macrophage-like cell line that elaborates generous amounts of MDCF in addition to another growth factor, interleukin-1 (IL-1). We have greatly simplified purification by adapting P388D1 cells to grow continuously serum-free in a defined medium. Serial application of ultrafiltration, gel filtration, and ion exchange chromatography has clearly separated MDCF and IL-1, both in terms of biochemical/biophysical properties and biological activities. Analysis by silver-stained SDS-PAGE slab gels reveals two major bands of protein that correspond to MDCF activity and one that corresponds to IL-1 activity. Companion studies of affinity-purified IL-1 confirm our findings that MDCF and IL-1 are distinct biochemical and biological entities. Using this greatly purified MDCF, we are now beginning to develop specific antisera using rabbits and monoclonal antibodies using rat-mouse hybridomas to identify and quantify MDCF for in vivo and in vitro experiments. Our aim is to compare this monokine with other known growth factors as an initial step in using these as probes to dissect the cellular events associated with proliferation. The results obtained should provide a foundation for definitive studies on the relation of macrophage-derived competence factor production in vivo to lesions characterized by mononuclear phagocyte accumulation, extensive fibroplasia, and collagen deposition. (J)
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Growth factors derived from a human malignant glioma cell line, U-251MG.
源自人类恶性神经胶质瘤细胞系 U-251MG 的生长因子。
DOI: 10.1007/bf00172915
发表时间: 1989
期刊: Journal of neuro-oncology
影响因子: 3.9
作者: [Kuratsu,J, Estes,JE, Yokota,S, MahaleyJr,MS, Gillespie,GY]
通讯作者: Gillespie,GY
Interferon-alpha and -gamma promote myeloid differentiation of HL-60, a human acute promyelocytic leukemia cell line.
干扰素-α 和-γ 促进人类急性早幼粒细胞白血病细胞系 HL-60 的骨髓分化。
DOI: --
发表时间: 1984
期刊: Journal of biological response modifiers
影响因子: --
作者: [Buessow,SC, Gillespie,GY]
通讯作者: Gillespie,GY
Macrophage-derived growth factor for fibroblasts and Interleukin-1 are distinct entities.
成纤维细胞的巨噬细胞衍生生长因子和 Interleukin-1 是不同的实体。
DOI: 10.1002/jlb.35.1.115
发表时间: 1984
期刊: Journal of leukocyte biology
影响因子: 5.5
作者: [Estes,JE, Pledger,WJ, Gillespie,GY]
通讯作者: Gillespie,GY
Tumoricidal activity of an acute promyelocytic leukemia cell line (HL-60) is augmented by human interferon alpha.
人干扰素 α 增强了急性早幼粒细胞白血病细胞系 (HL-60) 的杀肿瘤活性。
DOI: 10.1016/0145-2126(84)90101-2
发表时间: 1984
期刊: Leukemia research
影响因子: 2.7
作者: [Buessow,SC, Gillespie,GY, Mahaley,MS]
通讯作者: Mahaley,MS
8
    Glioblastoma tumor microenvironmental influence on acquired and inherent cancer therapy resistance.
    Experimental Glioma Animal Models Core
    CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
    海外基金